Related Experiment Video
Updated: Aug 6, 2026

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow
Published on: February 4, 2015
[Fetuin A in children with renal diseases]
Helena Ziółkowska1, Julita Wojnar, Małgorzata Pańczyk-Tomaszewska
1Katedra i Klinika Pediatrii i Nefrologii, Akademii Medycznej w Warszawie. nefrologia@litewska.edu.pl
Insights
Children with nephrotic syndrome have lower fetuin A levels, a protein inhibiting vascular calcification. This low fetuin A concentration may contribute to atherogenic lesions in these patients.
Area of Science:
- Pediatric Nephrology
- Biochemistry
- Vascular Biology
Background:
- Fetuin A is a circulating protein produced by the liver that inhibits vascular calcification.
- Understanding fetuin A levels in pediatric renal diseases is crucial for assessing associated risks.
Purpose of the Study:
- To determine serum fetuin A concentrations in children diagnosed with nephrotic syndrome (NS) and chronic renal failure (CRF).
- To compare fetuin A levels between pediatric patients with renal diseases and healthy controls.
- To investigate correlations between fetuin A levels and clinical parameters in pediatric patients.
Main Methods:
- Serum fetuin A was measured using ELISA in 53 children (18 with NS, 35 with CRF) and 22 healthy controls.
- Serum calcium, phosphorus, protein, albumin, total cholesterol, and triglycerides were analyzed.
- Daily proteinuria and parathyroid hormone levels (in CRF) were also assessed.
Main Results:
- Fetuin A concentration was significantly lower in children with NS (78.1 ng/ml) compared to healthy controls (101.4 ng/ml) and CRF patients (106.7 ng/ml).
- In NS patients, fetuin A levels correlated positively with serum calcium, phosphorus, and albumin, and negatively with total cholesterol and daily proteinuria.
- No significant correlations were found between fetuin A and analyzed parameters in control or CRF groups.
Conclusions:
- The reduced concentration of fetuin A in children with nephrotic syndrome may be an additional factor promoting atherogenic lesions.
- Fetuin A may play a role in the pathophysiology of vascular complications in pediatric nephrotic syndrome.
Unlabelled:
Fetuin A, 59 kDa protein, produced in the liver is a circulating inhibitor of vascular calcification. The aim of the study was to estimate a concentration of fetuin A in children with renal diseases. Fifty three children were examined: 18 with idiopathic nephrotic syndrome (NS) aged 2.5 to 14.5 years, mean 6.6 +/- 3.6 and 35 with chronic renal failure (CRF) aged 4.5 to 20 years, mean 13.3 +/- 3.9. The control group (K) consisted of 22 healthy children, aged from 6.5 to 17.5 years, mean 10.8 +/- 3.3. In all children serum concentration of fetuin A (ELISA method, BioVendor), calcium (sCa), phosphorus (sP), protein (P), albumin (Alb), total cholesterol (TC) and triglycerides (TG) were measured. The daily protein excretion in children with proteinuria (mg/kg/day) and the serum parathormone (PTH) level in children with CRF were analysed.
Results:
The concentration of fetuin A was the lowest in children with NS (78.1 +/- 24.5 ng/ml) and was statistically different (p=0.0003) than in group K (101.4 +/- 11 ng/ml) and group CRF (106.7 +/- 13.7 ng/ml). In group NS significant correlations were found between concentrations of fetuin A and sCa (r=0.62, p<0.01), P (r=0.59, p= 0.01) and Alb (r=0.64, p<0.01) and negative correlations with concentration of TC (r=-0.68, p<0.01) and daily proteinuria (r=-0.79, p<0.001). In groups K and CRF the correlations of fetuin A level and analysed parameters were not found.
Conclusion:
Low concentration of fetuin A in children with nephrotic syndrome may be the additional agent to promote the atherogenic lesions.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury V: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
